TIMP1

 TIMP metallopeptidase inhibitor 1, also known as TIMP1, a tissue inhibitor of metalloproteinases, is a glycoprotein that is expressed from the several tissues of organisms.

TIMP1
Protein TIMP1 PDB 1d2b.png
Available structures
PDBOrtholog search: PDBe RCSB
Identifiers
AliasesTIMP1, CLGI, EPA, EPO, HCI, TIMP, TIMP-1, TIMP metallopeptidase inhibitor 1
External IDsOMIM305370 MGI98752 HomoloGene36321 GeneCardsTIMP1
Gene location (Human)
X chromosome (human)
Chr.X chromosome (human)[1]
X chromosome (human)
Genomic location for TIMP1
Genomic location for TIMP1
BandXp11.3Start47,582,408 bp[1]
End47,586,789 bp[1]
RNA expression pattern
PBB GE TIMP1 201666 at fs.png
More reference expression data
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_003254

NM_001044384
NM_001294280
NM_011593

RefSeq (protein)

NP_003245
NP_003245.1

NP_001037849
NP_001281209
NP_035723

Location (UCSC)Chr X: 47.58 – 47.59 MbChr X: 20.87 – 20.87 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

This protein is a member of the TIMP family. The glycoprotein is a natural inhibitor of the matrix metalloproteinases (MMPs), a group of peptidases involved in degradation of the extracellular matrix. In addition to its inhibitory role against most of the known MMPs, the encoded protein is able to promote cell proliferation in a wide range of cell types, and may also have an anti-apoptotic function.

FunctionEdit

TIMP1 is an inhibitory molecule that regulates matrix metalloproteinases (MMPs), and disintegrin-metalloproteinases (ADAMs and ADAMTSs).[5] In regulating MMPs, TIMP1 plays a crucial role in extracellular matrix (ECM) composition, wound healing,[6] and pregnancy.[7][8][9]

The dysregulated activity of TIMP1 has been implicated in cancer.[10] In pregnancy, TIMP1 plays a regulatory role in the process of implantation, particularly the cytotrophoblast invasion of the uterine endometrium.[11] Additionally, it plays a role in regulating the transcriptional profile of fetal and placental tissues associated with the early stages of pregnancy.[12] Studies attribute this role to a mechanism involving the chromatin structure at the TIMP1 promoter region, implicating new pharmaceutical possibilities for the therapeutic regulation of TIMP1. Accordingly, TIMP1 can be manipulated in vitro using techniques, like the TIMP1 knock-out.[13][14][15]

Other namesEdit

  • Erythroid potentiating activity (EPA)
  • Human collagenase inhibitor (HCI)

Regulation of TIMP expressionEdit

Transcription of this gene is highly inducible in response to many cytokines and hormones. In addition, the expression from some but not all inactive X chromosomes suggests that this gene inactivation is polymorphic in human females. This gene is located within intron 6 of the synapsin I gene and is transcribed in the opposite direction.[16]

In adrenocortical cells the trophic hormone ACTH induces expression of TIMP-1 and the increase in TIMP expression is also associated with decreased collagenase activity.[17]

Increased expression of TIMP1 has been found to be associated with worse prognosis of various tumors, such as laryngeal carcinoma [18] or melanoma.[19]

This article uses material from the Wikipedia article
 Metasyntactic variable, which is released under the 
Creative Commons
Attribution-ShareAlike 3.0 Unported License
.